echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Xinruinuo Announces Appointment of Mr. Huang Haoyu as Chief Executive Officer

    Xinruinuo Announces Appointment of Mr. Huang Haoyu as Chief Executive Officer

    • Last Update: 2022-01-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    <>



    Xinruinuo was jointly established in China by Pivotal bioVenture Partners China, a leading venture capital fund in the life sciences field, Frazier Healthcare Partners, a well-known US medical fund, and Chinook Therapeutics (Nasdaq: KD NY),


    The CEO, Mr.



    Mr.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.